Article
A mutation in the gene encoding the vaccinia virus 37,000-M(r) protein confers resistance to an inhibitor of virus envelopment and release.
Journal of virology - 1 Jul 1991
Schmutz C, Payne L G, Gubser J, Wittek R
Abstract excerpt
Plaque formation in vaccinia virus is inhibited by the compound N1-isonicotinoyl-N2-3-methyl-4-chlorobenzoylhydrazine (IMCBH). We have isolated a mutant virus that forms wild-type plaques in the presence of the drug. Comparison of wild-type and mutant virus showed that both viruses produced similar amounts of infectious intracellular naked virus in the presence of the drug. In contrast to the mutant, no...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
